On July 24, 2019, Ms. Lisa D. Earnhardt, the former President and Chief Executive Officer of Intersect ENT, Inc. tendered her resignation as a member of the Board of Directors of the Company, effective as of July 24, 2019. Ms. Earnhardt’s resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. Effective as of July 22, 2019, the board appointed Mr. Thomas A. West, the Company’s President and Chief Executive Officer, to the Board to serve until the next annual meeting of stockholders. Except for his employment arrangement with the Company, there is no arrangement or understanding between Mr. West and any other person pursuant to which Mr. West was selected as a director. In connection with his appointment as the President and Chief Executive Officer, Mr. West has executed the Company’s standard form of indemnity agreement for directors and officers.